Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 1 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 1 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 3 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 3 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 400 microgram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 400 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 600 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 600 microgram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 600 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 600 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 400 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 400 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 1.25 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 1.25 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 1 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 1 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 5 mg/g eye ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 5 mg/g eye ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 620 microgram/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 620 microgram/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 1 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 1 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 200 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Atropine sulfate 200 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atropine sulfate |
Inferred relationship |
Some |
3 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atropine sulfate |
Inferred relationship |
Some |
3 |
Atropine sulfate anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Atropine sulfate |
Inferred relationship |
Some |
|